Susquehanna International Group’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.56M Buy
108,532
+40,279
+59% +$580K ﹤0.01% 2602
2025
Q1
$471K Sell
68,253
-4,354
-6% -$30K ﹤0.01% 4418
2024
Q4
$385K Buy
72,607
+1,198
+2% +$6.36K ﹤0.01% 4432
2024
Q3
$261K Buy
+71,409
New +$261K ﹤0.01% 4480
2024
Q2
Sell
-269,603
Closed -$938K 6749
2024
Q1
$938K Buy
269,603
+253,219
+1,546% +$881K ﹤0.01% 2729
2023
Q4
$23.4K Buy
+16,384
New +$23.4K ﹤0.01% 5658
2023
Q2
Sell
-108,947
Closed -$167K 6610
2023
Q1
$167K Buy
+108,947
New +$167K ﹤0.01% 4985
2022
Q4
Sell
-95,620
Closed -$118K 6906
2022
Q3
$118K Sell
95,620
-145,008
-60% -$179K ﹤0.01% 5182
2022
Q2
$402K Buy
240,628
+198,402
+470% +$331K ﹤0.01% 3617
2022
Q1
$104K Sell
42,226
-2,784
-6% -$6.86K ﹤0.01% 5131
2021
Q4
$168K Buy
45,010
+17,970
+66% +$67.1K ﹤0.01% 5064
2021
Q3
$170K Sell
27,040
-66,479
-71% -$418K ﹤0.01% 4788
2021
Q2
$922K Sell
93,519
-257,292
-73% -$2.54M ﹤0.01% 3084
2021
Q1
$3.28M Buy
350,811
+324,679
+1,242% +$3.03M ﹤0.01% 1595
2020
Q4
$125K Buy
26,132
+8,890
+52% +$42.5K ﹤0.01% 4428
2020
Q3
$69K Sell
17,242
-11,368
-40% -$45.5K ﹤0.01% 4175
2020
Q2
$131K Buy
28,610
+15,692
+121% +$71.9K ﹤0.01% 3856
2020
Q1
$42K Buy
+12,918
New +$42K ﹤0.01% 4248
2019
Q4
Sell
-28,470
Closed -$112K 4959
2019
Q3
$112K Buy
28,470
+6,199
+28% +$24.4K ﹤0.01% 4054
2019
Q2
$104K Buy
+22,271
New +$104K ﹤0.01% 4143
2019
Q1
Hold
0
4725
2018
Q3
Sell
-14,886
Closed -$55K 4876
2018
Q2
$55K Sell
14,886
-203,153
-93% -$751K ﹤0.01% 3399
2018
Q1
$916K Buy
218,039
+193,241
+779% +$812K ﹤0.01% 1570
2017
Q4
$146K Sell
24,798
-8,164
-25% -$48.1K ﹤0.01% 3238
2017
Q3
$142K Sell
32,962
-68,119
-67% -$293K ﹤0.01% 2839
2017
Q2
$386K Buy
+101,081
New +$386K ﹤0.01% 2585
2017
Q1
Sell
-56,866
Closed -$188K 4552
2016
Q4
$188K Buy
+56,866
New +$188K ﹤0.01% 3732
2016
Q3
Sell
-12,427
Closed -$51K 4101
2016
Q2
$51K Buy
+12,427
New +$51K ﹤0.01% 2999